Anacor Pharma (ANAC) Files $86.25M IPO

Article Stock Quotes (1) Comments (0)

Anacor Pharmaceuticals, Inc. (Nasdaq: ANAC) filed a registration statement with the U.S. Securities and Exchange Commission today for an Initial Public Offering of its common stock. The proposed maximum aggregate offering price is $86.25 million. The company plans to list their shares on The NASDAQ Global Market under the ticker “ANAC.”

The offering is being made through Citi, Deutsche Bank, Cowen and Company, and Wedbush PacGrow Life Sciences.

Anacor Pharma is a biopharmaceutical company focused on discovering, developing and commercializing novel small-molecule therapeutics derived from their boron chemistry platform.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• PTC Therapeutics (PTCT) Prices 8.37M IPO at $15/Share
• Loeb Boosts Sony (SNE) Stake, Continues Urging IPO on Entertainment Unit
• IPO of Nokia Siemens Best Outcome for Nokia (NOK) - Credit Suisse

Create E-mail Alert Related Categories

IPOs

Related Entities

Deutsche Bank, Citi, Cowen & Co

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?